View Cart (0 items)

Cephalon Wins Patent Suit Against Watson

March 28, 2011
/ Print / Reprints /
| Share More
/ Text Size+
Cephalon, Inc. announced that the United States District Court in Delaware has upheld the validity of Cephalon''s U.S. Patent Number 6,264,981 patent and found that Watson Pharmaceuticals, Inc.''s proposed generic version of FENTORA® (fentanyl buccal tablet) infringes that patent, reports PRNewswire. The Court also denied Watson''s motion to vacate a previously entered injunction preventing Watson from marketing its product. This decision pertained to patent litigation brought by Cephalon and its wholly-owned subsidiary CIMA Labs, Inc., against Watson Pharmaceuticals, Inc., and its wholly-owned subsidiary Watson Laboratories, Inc., regarding Cephalon''s FENTORA product.
You must login or register in order to post a comment.